Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
7.25
+0.21 (2.98%)
At close: Jun 18, 2026, 4:00 PM EDT
7.29
+0.04 (0.55%)
After-hours: Jun 18, 2026, 4:10 PM EDT

Burning Rock Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
76212739523110,017
Market Cap Growth
144.89%191.77%-23.75%-58.75%-97.69%313.84%
Enterprise Value
19.17149.738.5910.11107.069,795
Last Close Price
7.2520.156.759.3022.5095.30
PS Ratio
1.032.751.031.252.83125.36
PB Ratio
1.022.770.910.881.3834.50
P/TBV Ratio
0.140.400.130.120.200.54
EV/Sales Ratio
0.261.940.120.131.31122.59
Debt / Equity Ratio
0.060.050.050.000.010.03
Net Debt / Equity Ratio
-0.76-0.81-0.80-0.78-0.74-0.76
Net Debt / EBITDA Ratio
6.7513.161.531.131.001.88
Net Debt / FCF Ratio
11.5512.924.792.281.622.05
Asset Turnover
0.640.630.540.410.290.21
Inventory Turnover
2.552.462.331.751.451.50
Quick Ratio
2.712.672.572.902.574.38
Current Ratio
3.052.992.923.363.064.89
Return on Equity (ROE)
-11.28%-9.92%-51.38%-67.85%-64.67%-37.35%
Return on Assets (ROA)
-7.08%-6.24%-36.50%-50.76%-50.61%-32.22%
Return on Invested Capital (ROIC)
-24.29%-22.56%-126.93%-163.19%-169.53%-172.09%
Return on Capital Employed (ROCE)
-10.34%-9.20%-51.24%-68.55%-63.61%-36.83%
Buyback Yield / Dilution
-1.44%2.26%-5.05%0.20%2.35%-0.31%
Total Shareholder Return
-1.44%2.26%-5.05%0.20%2.35%-0.31%
SEC Filings: 10-K · 10-Q